Literature DB >> 15880754

High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt/PKB.

Tine Van de Sande1, Tania Roskams, Evelyne Lerut, Steven Joniau, Hein Van Poppel, Guido Verhoeven, Johannes V Swinnen.   

Abstract

Many human epithelial cancers, particularly those with a poor prognosis, express high levels of fatty acid synthase (FAS), a key metabolic enzyme linked to the synthesis of membrane phospholipids in cancer cells. In view of the recent finding that in the human prostate cancer cell line LNCaP, overexpression of FAS can be largely attributed to constitutive activation of the phosphatidylinositol-3 (PI3) kinase/Akt kinase pathway, the activation status of the Akt pathway, and whether this activation coincides with increased FAS expression, was examined in clinical prostate cancer tissues. Using well-preserved frozen prostatic needle biopsies and a sensitive Envision detection technique, S473-phosphorylated Akt (pAkt) was found in 11/23 low-grade prostatic intraepithelial neoplasia (PIN) lesions, in all (36/36) high-grade PINs, and in all (86/86) invasive carcinomas. Non-neoplastic tissues were negative. Interestingly, in low-grade PINs and low-grade carcinomas, pAkt was mainly cytoplasmic or membrane-bound and was associated with moderate elevation of FAS expression. In 24/36 high-grade PINs and 82/88 invasive carcinomas, pAkt was found at least partly in the nucleus. Greater nuclear pAkt staining, and higher FAS expression, correlated with a higher Gleason score. In the light of previous findings that pAkt plays a causative role in the overexpression of FAS in cancer cells in culture, these data strongly suggest that high-level expression of FAS in prostate cancer tissues is linked to phosphorylation and nuclear accumulation of Akt. Copyright 2005 Pathological Society of Great Britain and Ireland

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15880754     DOI: 10.1002/path.1760

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  53 in total

1.  GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cells.

Authors:  Sofia Cárdenas; Cecilia Colombero; Laura Panelo; Rambabu Dakarapu; John R Falck; Monica A Costas; Susana Nowicki
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-11-21       Impact factor: 4.698

2.  Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses.

Authors:  Uma Kant Misra; Salvatore Vincent Pizzo
Journal:  J Biol Chem       Date:  2015-02-26       Impact factor: 5.157

Review 3.  Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

Authors:  Witchuda Sukjoi; Jarunya Ngamkham; Paul V Attwood; Sarawut Jitrapakdee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  TDRG1 regulates chemosensitivity of seminoma TCam-2 cells to cisplatin via PI3K/Akt/mTOR signaling pathway and mitochondria-mediated apoptotic pathway.

Authors:  Yu Gan; Yong Wang; Zhengyu Tan; Jun Zhou; Riko Kitazawa; Xianzhen Jiang; Yuxin Tang; Jianfu Yang
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

5.  Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.

Authors:  Isabel R Schlaepfer; Leah Rider; Lindsey Ulkus Rodrigues; Miguel A Gijón; Colton T Pac; Lina Romero; Adela Cimic; S Joseph Sirintrapun; L Michael Glodé; Robert H Eckel; Scott D Cramer
Journal:  Mol Cancer Ther       Date:  2014-08-13       Impact factor: 6.261

6.  Role of sp transcription factors in the regulation of cancer cell metabolism.

Authors:  Michael C Archer
Journal:  Genes Cancer       Date:  2011-07

7.  Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer.

Authors:  Joachim Woenckhaus; Klaus Steger; Klaus Sturm; Karsten Münstedt; Folker E Franke; Irina Fenic
Journal:  Virchows Arch       Date:  2007-02-15       Impact factor: 4.064

8.  Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.

Authors:  Huai-Peng Lin; Zhou-Li Cheng; Ruo-Yu He; Lei Song; Meng-Xin Tian; Li-Sha Zhou; Beezly S Groh; Wei-Ren Liu; Min-Biao Ji; Chen Ding; Ying-Hong Shi; Kun-Liang Guan; Dan Ye; Yue Xiong
Journal:  Cancer Res       Date:  2016-10-10       Impact factor: 12.701

Review 9.  AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma.

Authors:  K J Schmitz; H Lang; J Wohlschlaeger; G C Sotiropoulos; H Reis; K W Schmid; H A Baba
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

10.  p63 promotes cell survival through fatty acid synthase.

Authors:  Venkata Sabbisetti; Arianna Di Napoli; Apryle Seeley; Angela M Amato; Esther O'Regan; Musie Ghebremichael; Massimo Loda; Sabina Signoretti
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.